Pharmacological Screening Using an FXN-EGFP Cellular Genomic Reporter Assay for the Therapy of Friedreich Ataxia

Li, Lingli; Voullaire, Lucille; Sandi, Chiranjeevi; Pook, Mark A.; Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Friedreich ataxia (FRDA) is an autosomal recessive disorder characterized by neurodegeneration and cardiomyopathy. The presence of a GAA trinucleotide repeat expansion in the first intron of the FXN gene results in the inhibition of gene expression and an insufficiency of the mitochondrial protein frataxin. There is a correlation between expansion length, the amount of residual frataxin and the severity of disease. As the coding sequence is unaltered, pharmacological up-regulation of FXN expression may restore frataxin to therapeutic levels. To facilitate screening of compounds that modulate FXN expression in a physiologically relevant manner, we established a cellular genomic reporter assay consisting of a stable human cell line containing an FXN-EGFP fusion construct, in which the EGFP gene is fused in-frame with the entire normal human FXN gene present on a BAC clone. The cell line was used to establish a fluorometric cellular assay for use in high throughput screening (HTS) procedures. A small chemical library containing FDA-approved compounds and natural extracts was screened and analyzed. Compound hits identified by HTS were further evaluated by flow cytometry in the cellular genomic reporter assay. The effects on FXN mRNA and frataxin protein levels were measured in lymphoblast and fibroblast cell lines derived from individuals with FRDA and in a humanized GAA repeat expansion mouse model of FRDA. Compounds that were established to increase FXN gene expression and frataxin levels included several anti-cancer agents, the iron-chelator deferiprone and the phytoalexin resveratrol.


Related Articles

  • Tourette Syndrome: Gene Expression as a Tool to Discover Drug Targets Liao, Isaac H.; Sharp, Frank R. // Neurotherapeutics;Jul2010, Vol. 7 Issue 3, p302 

    Summary: Gene expression microarrays are a high-throughput, cost-effective method for measuring the expression of all genes in a sample. By comparing the expression patterns of healthy controls to diseased subjects, the genetic regulatory pathways underlying and affected by the disease can be...

  • Identification of genes differentially expressed in association with acquired cisplatin resistance. Johnsson, A.; Zeelenberg, I.; Min, Y.; Hilinski, J.; Berry, C.; Howell, S.B.; Los, G. // British Journal of Cancer;10/15/2000, Vol. 83 Issue 8, p1047 

    The goal of this study was to identify genes whose mRNA levels are differentially expressed in human cells with acquired cisplatin (cDDP) resistance. Using the parental UMSCC10b head and neck carcinoma cell line and the 5.9-fold cDDP-resistant subline, UMSCC10b/Pt-S15, two suppressive...

  • ICB Invited Talk: Novel statistical approaches for data analysis in RNA interference high-throughput Screening technology. Zhang, Xiaohua Douglas // International MultiConference of Engineers & Computer Scientists;2007, plxv 

    RNA interference (RNAi) high throughput screening (HTS) allows the identification of genes associated with specific biological phenotypes. This technology has been hailed as the second genomics wave following the first genomics wave of gene expression microarrays and single nucleotide...

  • Beyond the Bottleneck. Manuso, James S. // Drug Discovery & Development;Jul2007, Vol. 10 Issue 7, p48 

    The author offers his insights on how pharmaceutical companies can accelerate the discovery and development process of new drugs in the U.S. According to the author, a solution to the problem of drug development is to increase the amount of information available to organization in drug discovery...

  • What's In a Cell? DePalma, Angelo // Drug Discovery & Development;Nov2007, Vol. 10 Issue 11, Special section p26 

    The article offers information on cell-based assays as a platform for drug development in the U.S. Bill Severson, a research virologist at Southern Research Institute, Birmingham, Alabama, has developed high-throughput, cell-based infectivity assays for pathogenic viruses including SARS, avian...

  • High-content screening: getting more from less. McCoy, jR., J. Philip // Nature Methods;May2011, Vol. 8 Issue 5, p390 

    The author comments on an article by Daniel Ehrlich and colleagues published within this issue of the periodical on the efficacy of high-content screening (HCS) analysis for drug discovery. It is stated that, HCS technique uses automated analysis of cell images to facilitate drug discovery and...

  • Gene Expression Analysis for High Throughput Screening Applications. Pinhasov, Albert; Mei, Jay; Amaratunga, Dhammika; Amato, Frank A.; Hong Lu; Kauffman, Jack; Hong Xin; Brenneman, Douglas E.; Johnson, Dana L.; Andrade-Gordon, Patricia; Ilyin, Sergey E. // Combinatorial Chemistry & High Throughput Screening;Mar2004, Vol. 7 Issue 2, p133 

    To meet growing needs for high throughput gene expression profiling, we established a new automated high throughput TaqMan RT-PCR method for quantitative mRNA expression analysis. In this method, the AllegroTM (Zymark) system conducts all sample tracking and liquid handling steps, and ABI...

  • Editorial. Wesche, Holger; Shou-Hua (Josh) Xiao; Young, Steve // Combinatorial Chemistry & High Throughput Screening;Mar2008, Vol. 11 Issue 3, p174 

    The article explores the developments in the use of high throughput technologies. It says that such techniques were conducted primarily by the pharmaceutical industry for determining small molecule modulators for novel drug targets. It mentions that these technologies were later embraced by...

  • THINK Back: KNowledge-based Interpretation of High Throughput data. Farfán, Fernando; Jun Ma; Sartor, Maureen A.; Michailidis, George; Jagadish, Hosagrahar V. // BMC Bioinformatics;2012 Supplement 2, Vol. 13 Issue Suppl 2, p1 

    Results of high throughput experiments can be challenging to interpret. Current approaches have relied on bulk processing the set of expression levels, in conjunction with easily obtained external evidence, such as cooccurrence. While such techniques can be used to reason probabilistically, they...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics